Revolutionary glucose-responsive insulin NNC2215 offers hope for diabetics, managing blood sugar levels without hypoglycemia ...

It was a moment of inspiration in the toilets of a London train station - and it changed the lives of people with diabetes across the world. Dr Sheila Reith was administering insulin to her ...

The hemoglobin A1C test is a useful tool to help monitor glucose control or diagnose diabetes, but it’s not foolproof. Certain health conditions or medications may interfere with the test ...

But, as blood glucose rises, the glucoside is replaced by glucose itself, triggering the insulin to shift its shape and become active, helping bring blood sugar levels down to safer ranges. Reacting ...

Diabetes occurs when the pancreas does not produce enough insulin in the body to ... The NNC2215 molecule consists of two major parts in its structure—a ring-shaped structure called a macrocycle, and ...

Diabetes is a common and chronic condition ... the B29 region (macrocycle) and the B1 region (glucoside). The glucose-binding ability of the macrocycle was tested using calorimetry, and the ...

Diabetes demands attention — constant ... By adding a glucose-binding macrocycle and glucoside to the insulin molecule, the research team created the glucose-dependent switch.

According to researchers, the drug holds great promise for the tens of millions of insulin-requiring diabetics worldwide. Low blood glucose, or hypoglycemia, can be dangerous for diabetics.

New research highlights that 65.8% of diabetic men suffer from erectile dysfunction. Early detection and better diabetes control are key to reducing this common yet serious condition. Study ...

Patients with diabetic foot ulcers and hard to heal risk factors who received topical ON101 achieved higher complete healing rates and had shorter times to complete healing than patients who received ...